BioNTech develops mRNA cancer immunotherapies, next-generation immunomodulators and targeted therapies in oncology, and vaccines against infectious diseases.

BioNTech SE (/ biːˈɒntɛk / bee-ON-tek; or / baɪˈɒntɛk / bye-ON-tek[3] short for Biopharmaceutical New Technologies) is a German multinational biotechnology company headquartered in Mainz …

Dec 23, 2025 · BioNTech SE (NASDAQ:BNTX) is a German biotechnology company that develops and commercializes novel immunotherapies and vaccines for cancer and infectious …

Dec 3, 2025 · Biopharmaceutical New Technologies, or BioNTech, is a global, fully integrated next-generation immunotherapy company pioneering novel therapies for cancer, infectious …

Previously, the Pfizer-BioNTech vaccine was available in the United States only under an Emergency Use Authorization (EUA), a distinct regulatory pathway that allows FDA to …

BioNTech SE (BioNTech) is a biotechnology company that develops immunotherapies for cancer and infectious diseases.

BioNTech SE (/ biːˈɒntɛk / bee-ON-tek; or / baɪˈɒntɛk / bye-ON-tek[3] short for Biopharmaceutical New Technologies) is a German multinational biotechnology company headquartered in Mainz …

BioNTech is a global biopharmaceutical company pioneering novel investigative therapies for cancer and infectious diseases. We are committed to transforming how cancer is treated.

Jun 25, 2025 · The Fact Sheets for Healthcare Providers and for Recipients and Caregivers for Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19, which are authorized for …

The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2][37] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company …